Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-29

Clinical Trial Update: Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how ovarian hormone withdrawal influences anhedonia and reward sensitivity in women with premenstrual exacerbations of depress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Major Depressive Disorder | Phase 4 | Status: RECRUITING